About Us
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
Website
http://www.molecularpartners.com
Phone
Phone number is +41 44 755 77 00
Verified page
September 12, 2023
Industry
Biotechnology Research
Company size
51-200 employees
LinkedIn members who’ve listed Molecular Partners as their current workplace on their profile.
Headquarters
Schlieren-Zürich, Zürich Area
Founded
2004
Specialties
DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, Immunology and other indications, Virology, Ophthalmology, Intellectual property of DARPins, Repeat proteins and protein engineering, and Collaborations with other leading pharmaceutical companies
